Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
2.615
-0.195 (-6.94%)
Mar 31, 2025, 2:30 PM EDT - Market open
Tivic Health Systems Employees
Tivic Health Systems had 9 employees as of December 31, 2023. The number of employees decreased by 7 or -43.75% compared to the previous year.
Employees
9
Change (1Y)
-7
Growth (1Y)
-43.75%
Revenue / Employee
$86,667
Profits / Employee
-$628,333
Market Cap
1.62M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9 | -7 | -43.75% |
Dec 31, 2022 | 16 | 9 | 128.57% |
Dec 31, 2021 | 7 | -1 | -12.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TIVC News
- 9 days ago - Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth - Business Wire
- 17 days ago - Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast - Business Wire
- 25 days ago - Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System - Business Wire
- 26 days ago - Tivic Health Systems, Inc. Announces Reverse Stock Split - Business Wire
- 4 weeks ago - Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Business Wire
- 5 weeks ago - Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team - Business Wire
- 6 weeks ago - Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire